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ABSTRACT
Acute necrotizing encephalopathy of childhood (ANEC) is a rare condition which is important for clinicians to 
recognize as it has a high mortality rate and can result in significant neurological morbidities. It presents as acute 
encephalopathy with radiological findings of symmetrical brain lesions in bilateral thalami, putamen, brain stem teg-
mentum, internal capsule, periventricular white matter and cerebellar medulla. Intravenous methylprednisolone is 
the mainstay of treatment. Immunoglobulin therapy and therapeutic hypothermia may be used as adjunctive therapy 
in cases with severe clinical and neuroradiological presentation. We present a case of severe ANEC and discuss the 
clinical manifestations, neuroimaging and management options.
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INTRODUCTION
Acute necrotizing encephalopathy of childhood (ANEC) 
is a rare neurological disease that predominantly affects 
children of Oriental origin, with the peak incidence 
occurring between 6 to 18 months of age (1). This 
clinical entity was first described by Mizuguchi et al. 
in previously healthy Japanese children with acute 
encephalopathy, whom were found to have symmetrical 
multifocal brain lesions (1). Children with ANEC have 
devastating neurological sequelae, with mortality rate 
approaching 30% (1). Unfortunately, there is no specific 
therapy for this disease, but the prognosis has improved 
since 1990s with better recognition of this clinical 
entity (1). Early corticosteroids therapy has been found 
to improve the neurological and survival outcome in 
children with ANEC where brain stem lesions are not 
present (2). We present a severe case of ANEC who was 
treated early with intravenous methylprednisolone, but 
yet still succumbed to her illness.  
CASE REPORT
A previously healthy 2-year-old girl presented to the 
emergency ward with one-day history of fever, diarrhea 
and vomiting. She was less active and more sleepy 
than usual but still able to respond to her mother when 
being called. On the day of presentation, she had 4 
episodes of seizures occurring within the duration of 
1-hour. Each episode lasted for 5-10min with altered 
consciousness in between each seizure episode. 
The seizures were aborted by suppository diazepam 
followed by intravenous loading dose of phenytoin. 
At presentation, she was tachycardic with pulse rate of 
150/min, hypotensive with the blood pressure of 77/38 
mmHg and temperature was 37.7oC.  She had a Glasgow 
Coma Scale (GCS) of 8/15 and her pupils were 2mm and 
reactive bilaterally. Both upper limbs and lower limbs 
were hypertonic with brisk reflexes. She had up going 
plantar reflexes. There was no neck stiffness. Kemig’s 
and Brudzinski’s signs were negative. Her GCS declined 
to 6/15 twelve hours following the last seizure and she 
was intubated for cerebral protection. 
Her first full blood count was normal (Hb 13.3g/dL WCC 
9.9x109/L and platelet 291x109/L). However, at day 6 of 
admission, investigations revealed leucopaenia (WCC 
3.6 x 109/L) and mild thrombocytopaenia (platelet 121 
x 109/L). Coagulation profile was normal (PT 15.4s, INR 
1.2 and APTT 32.9s). Urea was raised 8 mmol/L(normal 
2.1-6.5 mmol/L) but serum creatinine was normal 
(55 mmol/L). Serum ammonia was 18.2 μmol/L (0-80 
μmol/L), and serum glucose was 10.5 mmol/L. Her liver 
function was normal (bilirubin 2.7 μmol/L, ALT 46 U/L, 
ALP 178 U/L). A Computed Tomography of the brain 
performed on the day of presentation showed bilateral 
symmetrical thalamic hypodensities. The symmetrical 
changes were further demonstrated in the caudate, 
putamen, thalami, brain stem and cerebellum on a 
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DISCUSSION
The diagnostic criteria for ANEC include acute 
encephalopathy in previously well children with 
symmetrical multifocal brain lesions within both thalami, 
putamen, internal capsule, brain stem tegmentum, 
periventricular white matter and cerebellar medulla 
with the exclusion of other neurological conditions 
(1). In patients with ANEC, altered conscious state is 
typically preceded by coryza symptoms but vomiting 
and diarrhoea are also recognized features, as seen in 
our patient (1). The commonest viruses identified in 
these individuals are influenza A or B, human herpes 
virus 6 and 7 (HHV-6 and HHV-7), suggesting an 
immune mediated inflammatory response to the viral 
illness as a possible explanation for the pathogenesis of 
ANEC (1). The breakdown of blood- brain barrier due to 
vasoactive substances and cytokines is evident by the 
histopathologic findings of edema and necrosis at the 
regions of the mutifocal brain lesions (1). 
The laboratory abnormalities associated with ANEC 
are thrombocytopenia, hematologic changes of 
disseminated intravascular coagulation and elevated 
serum aspartate transaminase and alanine transaminase 
without hyperammonaemia and hypoglycemia (1). 
MRI brain performed on the same day (Fig 1A and 1B, 
1C). The gradient echo (GRE) axial image also revealed 
haemorrhagic foci in both thalami and periventricular 
white matter. (Fig 1D). A diagnosis of ANEC was 
made and IV methylprednisolone 30mg/kg/day in 3 
divided doses was commenced at 17 hours after initial 
presentation and continued for 5 days. She was also 
treated with intravenous phenytoin, ceftriaxone and 
acyclovir. She did not have a recurrence of seizure after 
admission.
On the second day of presentation, her condition 
continued to deteriorate. She became hypotensive and 
required inotropic support. Both her pupils became fixed 
and dilated, 7 mm bilaterally. On the 8th day of ICU 
admission, she became polyuric due to central diabetes 
insipidus and unfortunately succumbed to death. Blood 
culture taken on admission had no growth. Post mortem 
cerebrospinal fluid (CSF) studies revealed no cells, 
raised protein 757 mg/L(normal range 50-400 mg/L) and 
a normal glucose of 4.66 mmol/L. CSF PCR for influenza 
A and influenza B virus, herpes simplex virus, coxsackie 
virus A, B and 16, enterovirus 71 and 70, echovirus and 
poliovirus were negative. Gram stain and CSF culture did 
not reveal any organism. Postmortem histopathological 
examination of the brain was not done.
Figure 1: (A) T1W Axial 
image showing bilateral 
low intensity changes with-
in the thalami (1), head of 
the caudate nuclei (2) and 
putamina (3). (B) T1W Sag-
ittal image showing low 
signal intensities within the 
thalamus (1), brainstem 
(2) and cerebellum (3). 
(C) FLAIR coronal image 
showing extensive bilateral 
symmetrical high intensity 
changes within the white 
matter extending to the 
grey white matter junction 
(1), both thalami (2) and the 
brain stem (3). (D) GRE axi-
al image showing blooming 
artifact within the thalami 
(arrow heads) and the pe-
riventricular white matter 
(white arrows) suggesting 
haemorrhagic foci.                                
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Creatinine kinase and serum urea can sometimes be 
raised if there is muscle or kidney involvement. CSF 
studies usually reveal no pleocytosis, but an increase 
in protein is commonly observed due to plasma protein 
extravasation and disintegrating neural tissue protein at 
the sites of periventricular necrotic brain lesions (1). The 
symmetrical distribution and characteristic affected sites 
from MRI as well as typical clinical presentation in our 
patient fitted the diagnosis of ANEC. Viral encephalitis 
and acute disseminated encephalomyelitis (ADEM) are 
unlikely as the brain lesions in these two conditions are 
asymmetrical and pleocytosis would be expected in 
the CSF studies. Reyes syndrome is also unlikely in the 
absence of liver dysfunction, hyperammonaemia and 
hypoglycemia.
        
Our patient showed rapid deterioration in conscious level 
with coma ensuing within 24 hours despite intravenous 
methylprednisolone being started at 17 hours of 
admission. The poor prognostic factors associated with 
her were young age of less than 4 years, brain stem 
involvement, raised CSF protein and extensive cerebral 
and cerebellar involvement with thalami haemorrhage. 
A study conducted by Wong AM et al. showed that 
clinical outcome of the patient corresponded with the 
MR imaging score, which is a composite score derived 
from the presence of haemorrhage or cavitation and 
extent of brain stem and white matter (cerebral and 
cerebellar) involvement (2). 
There is no definitive recommended therapy for ANEC. 
Intensive care, symptomatic treatment, therapeutic 
hypothermia, antiviral therapy and immunomodulator 
therapy have been used in ANEC with steroids being 
the mainstay of treatment. Steroids decreases vascular 
permeability by suppressing the release of cytokines 
in the acute inflammatory stage. Our patient however 
showed poor response to steroids as her neurological 
status continued to deteriorate rapidly even though she 
was treated early with methylprednisolone. The use of 
IV methylprednisolone as monotherapy in our patient 
might not be adequate as she had extensive brain 
lesions including brain stem involvement. Okumura et 
al also reported that intravenous methylprednisolone 
administration within 24 hours of presentation only 
improved the outcome in cases where brain stem lesions 
were not present (3). Patients with severe clinical and 
neuroradiological presentation might benefit from other 
treatment modalities in addition to steroids therapy. Early 
combined therapy of both steroid and immunoglobulins 
had been found to be useful in avoiding a fatal outcome 
in few reported cases of severe ANEC although these 
patients developed significant neurodevelopmental 
morbidities later on (4). Early therapeutic hypothermia 
used in combination with steroids has also been 
shown to have favourable outcome in severe ANEC 
and is another treatment option to be considered (5). 
Therapeutic hypothermia has been postulated to reduce 
pro-inflammatory cytokines and hence reduce brain 
injury. The use of therapeutic hypothermia combined 
with steroid therapy has shown promising results in 
Japan where ANEC cases are more prevalent.
CONCLUSION
Early diagnosis of ANEC is not too difficult with better 
recognition of this neurological entity and characteristic 
radiological findings demonstrable in the early stage of 
the disease. Patients with extensive white matter lesions 
with haemorrhage and brain stem involvement have 
poor prognosis even though they are treated early with 
intravenous methylprednisolone. The MRI changes of a 
patient with ANEC should be used to prognosticate the 
disease progression. Other adjunct treatment modalities 
besides corticosteroids should be considered in the case 
of severe ANEC. Due to the rarity of this condition, firm 
evidence on treatment guidelines are unfortunately 
still lacking. Randomised controlled trials on different 
treatment modalities are needed to provide clear 
evidence to guide clinicians on the most appropriate 
treatment regimen for this condition.   
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